Identification and Quantification of a New Family of Peptide Endocannabinoids (Pepcans) Showing Negative Allosteric Modulation at CB1Receptors

Cannabinoid receptor trafficking in peripheral cells is dynamically regulated by a binary biochemical switch

(2012) Jonas Kleyer et al.   BIOCHEMICAL PHARMACOLOGY

Indole-2-carboxamides as Allosteric Modulators of the Cannabinoid CB1 Receptor

(2012) Francesco Piscitelli et al.   JOURNAL OF MEDICINAL CHEMISTRY

Online immunoaffinity LC/MS/MS. A general method to increase sensitivity and specificity: How do you do it and what do you need?

(2011) Dawn R. Dufield et al.   METHODS

Hemoglobin-derived Peptides as Novel Type of Bioactive Signaling Molecules

(2010) Ivone Gomes et al.   AAPS Journal

Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic effects in skin

(2010) Marco Leonti et al.   BIOCHEMICAL PHARMACOLOGY

Binding of the Hemopressin Peptide to the Cannabinoid CB1Receptor: Structural Insights

(2010) Mario Scrima et al.   BIOCHEMISTRY

Hemopressins and other hemoglobin-derived peptides in mouse brain: comparison between brain, blood, and heart peptidome and regulation inCpefat/fatmice

(2010) Julia S. Gelman et al.   JOURNAL OF NEUROCHEMISTRY

The Peptide Hemopressin Acts through CB1 Cannabinoid Receptors to Reduce Food Intake in Rats and Mice

(2010) G. T. Dodd et al.   JOURNAL OF NEUROSCIENCE

Alterations in the Hippocampal Endocannabinoid System in Diet-Induced Obese Mice

(2010) F. Massa et al.   JOURNAL OF NEUROSCIENCE

Allosteric modulation of G protein-coupled receptors: A pharmacological perspective

(2010) Peter Keov et al.   NEUROPHARMACOLOGY

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

(2010) R. G. Pertwee et al.   PHARMACOLOGICAL REVIEWS

Positive allosteric modulation of the human cannabinoid (CB1) receptor by RTI-371, a selective inhibitor of the dopamine transporter

(2009) Hernán A. Navarro et al.   BRITISH JOURNAL OF PHARMACOLOGY

Novel endogenous peptide agonists of cannabinoid receptors

(2009) Ivone Gomes et al.   FASEB JOURNAL

Design and pre-clinical profiling of a Plasmodium falciparum MSP-3 derived component for a multi-valent virosomal malaria vaccine

(2009) Marco Tamborrini et al.   MALARIA JOURNAL

An Automated and Multiplexed Method for High Throughput Peptide Immunoaffinity Enrichment and Multiple Reaction Monitoring Mass Spectrometry-based Quantification of Protein Biomarkers

(2009) Jeffrey R. Whiteaker et al.   MOLECULAR & CELLULAR PROTEOMICS

Generation of Monoclonal Antibodies against Highly Conserved Antigens

(2009) Hongzhe Zhou et al.   PLoS One

Proteome wide screening using peptide affinity capture

(2009) Oliver Poetz et al.   PROTEOMICS

“The Tools of the Trade” – An Overview of the Pharmacology of the Endocannabinoid System

(2008) Christopher Fowler   CURRENT PHARMACEUTICAL DESIGN

Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids

(2008) Lumír Ondřej Hanuš   MEDICINAL RESEARCH REVIEWS

Use of an Immunoaffinity-Mass Spectrometry-based Approach for the Quantification of Protein Biomarkers from Serum Samples of Lung Cancer Patients

(2008) Gordon R. Nicol et al.   MOLECULAR & CELLULAR PROTEOMICS

Targeting the endocannabinoid system: to enhance or reduce?

(2008) Vincenzo Di Marzo   NATURE REVIEWS DRUG DISCOVERY

Beta-caryophyllene is a dietary cannabinoid

(2008) Jürg Gertsch et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats

(2007) J G Horswill et al.   BRITISH JOURNAL OF PHARMACOLOGY

Involvement of the Carboxyl Terminus of the Third Intracellular Loop of the Cannabinoid CB1 Receptor in Constitutive Activation of Gs

(2003) Vasiliki Abadji et al.   JOURNAL OF NEUROCHEMISTRY